（Billions of yen）
*Since FY2023, revenue and operating income from the non-destructive testing materials and equipments were reclassified from the Materials segment to the Healthcare segment. The data for the previous consolidated fiscal year has been restated in line with the change.
（Billions of yen）
*Since FY2023, revenue and operating income from the non-destructive testing materials and equipments were reclassified from the Materials segment to the Healthcare segment. The data for the previous consolidated fiscal year has been restated in line with the change.
（Billions of yen）
（Billions of yen）
Consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America.
Caution
-
These data are prepared based on the financial results reports.
-
The frequency of updates may change in accordance with changes to the format of the financial results reports.
-
Please see the financial results reports and other materials for detailed information regarding the settlement of accounts.
-
The contents of these data will not immediately reflect corrections to the financial results reports when announced.
-
While we pay due caution to the conversion of data for the posting, please note that there is a possibility that errors may occur in the information due to uncontrollable circumstances, such as the unauthorized alteration of contents by a third party or mechanical defects resulting from equipment malfunction.
-
Service provided by Nomura Investor Relations Co., Ltd.
Powered by ShareWith